1.Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia.
Elis J LIRA DOS SANTOS ; Kenta NAKAJIMA ; Julien PO ; Ayako HANAI ; Volha ZHUKOUSKAYA ; Martin BIOSSE DUPLAN ; Agnès LINGLART ; Takashi SHIMADA ; Catherine CHAUSSAIN ; Claire BARDET
International Journal of Oral Science 2023;15(1):53-53
Elevated fibroblast growth factor 23 (FGF23) in X-linked hypophosphatemia (XLH) results in rickets and phosphate wasting, manifesting by severe bone and dental abnormalities. Burosumab, a FGF23-neutralizing antibody, an alternative to conventional treatment (phosphorus and active vitamin D analogs), showed significant improvement in the long bone phenotype. Here, we examined whether FGF23 antibody (FGF23-mAb) also improved the dentoalveolar features associated with XLH. Four-week-old male Hyp mice were injected weekly with 4 or 16 mg·kg-1 of FGF23-mAb for 2 months and compared to wild-type (WT) and vehicle (PBS) treated Hyp mice (n = 3-7 mice). Micro-CT analyses showed that both doses of FGF23-mAb restored dentin/cementum volume and corrected the enlarged pulp volume in Hyp mice, the higher concentration resulting in a rescue similar to WT levels. FGF23-mAb treatment also improved alveolar bone volume fraction and mineral density compared to vehicle-treated ones. Histology revealed improved mineralization of the dentoalveolar tissues, with a decreased amount of osteoid, predentin and cementoid. Better periodontal ligament attachment was also observed, evidenced by restoration of the acellular cementum. These preclinical data were consistent with the retrospective analysis of two patients with XLH showing that burosumab treatment improved oral features. Taken together, our data show that the dentoalveolar tissues are greatly improved by FGF23-mAb treatment, heralding its benefit in clinics for dental abnormalities.
Humans
;
Male
;
Mice
;
Animals
;
Familial Hypophosphatemic Rickets/pathology*
;
Fibroblast Growth Factor-23
;
Retrospective Studies
;
Fibroblast Growth Factors/metabolism*
;
Bone and Bones/metabolism*
;
Phosphates/therapeutic use*
2.Nucleus-targeted Dmp1 transgene fails to rescue dental defects in Dmp1 null mice.
Shu-Xian LIN ; Qi ZHANG ; Hua ZHANG ; Kevin YAN ; Leanne WARD ; Yong-Bo LU ; Jian-Quan FENG
International Journal of Oral Science 2014;6(3):133-141
Dentin matrix protein 1 (DMP1) is essential to odontogenesis. Its mutations in human subjects lead to dental problems such as dental deformities, hypomineralization and periodontal impairment. Primarily, DMP1 is considered as an extracellular matrix protein that promotes hydroxyapatite formation and activates intracellular signaling pathway via interacting with αvβ3 integrin. Recent in vitro studies suggested that DMP1 might also act as a transcription factor. In this study, we examined whether full-length DMP1 could function as a transcription factor in the nucleus and regulate odontogenesis in vivo. We first demonstrated that a patient with the DMP1 M1V mutation, which presumably causes a loss of the secretory DMP1 but does not affect the nuclear translocation of DMP1, shows a typical rachitic tooth defect. Furthermore, we generated transgenic mice expressing (NLS)DMP1, in which the endoplasmic reticulum (ER) entry signal sequence of DMP1 was replaced by a nuclear localization signal (NLS) sequence, under the control of a 3.6 kb rat type I collagen promoter plus a 1.6 kb intron 1. We then crossbred the (NLS)DMP1 transgenic mice with Dmp1 null mice to express the (NLS)DMP1 in Dmp1-deficient genetic background. Although immunohistochemistry demonstrated that (NLS)DMP1 was localized in the nuclei of the preodontoblasts and odontoblasts, the histological, morphological and biochemical analyses showed that it failed to rescue the dental and periodontal defects as well as the delayed tooth eruption in Dmp1 null mice. These data suggest that the full-length DMP1 plays no apparent role in the nucleus during odontogenesis.
Animals
;
Cell Nucleus
;
genetics
;
Codon, Initiator
;
genetics
;
Collagen Type I
;
genetics
;
Endoplasmic Reticulum
;
genetics
;
Extracellular Matrix Proteins
;
genetics
;
Familial Hypophosphatemic Rickets
;
genetics
;
Gene Targeting
;
methods
;
Genetic Vectors
;
genetics
;
Humans
;
Introns
;
genetics
;
Methionine
;
genetics
;
Mice, Inbred C57BL
;
Mice, Transgenic
;
Mutation
;
genetics
;
Odontoblasts
;
cytology
;
Odontogenesis
;
genetics
;
Periodontal Diseases
;
genetics
;
Periodontal Ligament
;
pathology
;
Phosphoproteins
;
genetics
;
Promoter Regions, Genetic
;
genetics
;
Tooth Abnormalities
;
genetics
;
Tooth Eruption
;
genetics
;
Transcription Factors
;
genetics
;
Transgenes
;
genetics
;
Valine
;
genetics
;
Young Adult